For Immediate Release
New Research from Dana-Farber Cancer Institute Examines Long-Term Anxiety in Pediatric Brain Tumor Survivors
Contact: Kathryn Ryan
New Rochelle, NY, October 9, 2018—A new study compared the risk of anxiety and depression several years after the successful treatment of brain tumor relapse versus clinically significant psychosocial impairment in adolescents and young adults who did experience relapse during the ensuing years. The proportion of survivors of a relapse who were identified as clinically anxious (30.4%) was more than 3 times greater than the proportion of non-relapsed survivors who had an elevated level of anxiety (9.4%), according to the study published in Journal of Adolescent and Young Adult Oncology (JAYAO), a multidisciplinary peer-reviewed publication from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Journal of Adolescent and Young Adult Oncology (JAYAO) website through November 9, 2018.
Candice Chow, PhD and colleagues from Dana-Farber Cancer Institute, Boston, MA coauthored the article entitled “Adolescent and Young Adult Brain Tumor Survivors Report Increased Anxiety Even Years After Successful Treatment for Relapse.” The researchers link survivors – and relapse survivors even more so—with a persistent sense of uncertainty about the future. Contributing to this uncertainty is the ongoing need for continued and close monitoring for disease recurrence. The frequent follow-up visits and scans to check for relapse can cause anxiety. The study results indicate the need for survivors to receive not only follow-up medical care, but also integrated psychosocial assessment and intervention.
About the Journal
Journal of Adolescent and Young Adult Oncology (JAYAO) is a bimonthly peer-reviewed journal dedicated to the promotion of interdisciplinary research, education, communication, and collaboration between health professionals in AYA oncology. Led by Leonard S. Sender, MD, University of California, Irvine and CHOC Children's Hospital Hyundai Cancer Institute, Orange, CA, JAYAO provides a forum for AYA cancer research and practice advances for all professional participants and researchers in care for AYA-aged cancer patients and survivors. Complete tables of content and a sample issue may be viewed on the Journal of Adolescent and Young Adult Oncology (JAYAO) website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Palliative Medicine and Cancer Biotherapy and Radiopharmaceuticals. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.